🔴 Lantern Pharma is trading 6.4% down today after announcing a roughly $4 million direct offering

Lantern Pharma is trading at $1.02 (-6.42%) after announcing a registered direct offering expected to raise about $4 million before expenses.

• The offering includes 3,669,725 shares or pre-funded warrants priced at $1.09 each.
• A concurrent private placement includes warrants for up to 3,669,725 additional shares, potentially raising another $4 million if exercised.
• Closing is expected around September 30, 2026, subject to customary conditions.